IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer

Published:2017-06 Issue:3 Volume:145 Page:453-461
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Felices M.,Chu S.,Kodal B.,Bendzick L.,Ryan C.,Lenvik A.J.,Boylan K.L.M.,Wong H.C.,Skubitz A.P.N.,Miller J.S.,Geller M.A.

Funder

National Cancer Institute

Minnesota Ovarian Cancer Alliance

Mayo Clinic Ovarian Cancer SPORE

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference45 articles.

1. Cancer statistics;Jemal;CA Cancer J. Clin.,2010

2. Immunotherapy for ovarian cancer: what's next?;Kandalaft;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2011

3. Unmet needs in ovarian cancer: dividing histologic subtypes to exploit novel targets and pathways;Galic;Curr. Cancer Drug Targets,2013

4. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer;Zhang;N. Engl. J. Med.,2003

5. Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma;Tomsova;Gynecol. Oncol.,2008

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment;Bioactive Materials;2024-12

2. NK cell line modified to express a potent, DR5 specific variant of TRAIL, show enhanced cytotoxicity in ovarian cancer models;Heliyon;2024-08

3. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

4. iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma;Frontiers in Immunology;2024-07-19

5. Human NK cells and cancer;OncoImmunology;2024-07-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3